<DOC>
	<DOCNO>NCT01617772</DOCNO>
	<brief_summary>The aim present study compare effect simvastatin L-carnitine coadministration versus simvastatin , L-Carnitine monotherapy liver enzyme ( AST , ALT ) liver elasticity NASH patient .</brief_summary>
	<brief_title>Atorvastatin , L-Carnitine Non-Alcoholic Steatohepatitis</brief_title>
	<detailed_description>Nonalcoholic fatty liver disease ( NAFLD ) represent spectrum disease range steatosis steatohepatitis ( nonalcoholic steatohepatitis , NASH ) cirrhosis . Statins competitive inhibitor HMG CoA reductase , rate-limiting step cholesterol biosynthesis . They occupy portion bind site HMG CoA , block access substrate active site enzyme . A reduction intrahepatic cholesterol lead increase LDL receptor turnover result enhance rate hepatic LDL receptor cycling . On hand recent study implicate several important cellular process signal pathway affect abnormal lipid metabolism , result specific biochemical , histological , clinical change associate NAFLD . Maybe statins , lipid lower agent , effect reduction intrahepatic cholesterol , affect abnormal lipid metabolism NASH . L- carnitine , improve outcome NASH , reduce lipid level , limit oxidative stress , modulate inflammatory response . It perform number essential intracellular metabolic function , fatty acid transport , detoxification potentially toxic metabolite , regulation mitochondrial acyl-Co A / CoA ratio , stabilization cell membrane . It pivotal role transport long chain fatty acid across inner mitochondrial membrane .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>NASH diagnose basis follow criterion : 1 . Imaging technique show evidence hepatic steatosis 2 . Increased ALT 1.5 time normal ( normal : 20 IU/L woman , 30 men ) two occasion three month apart . Patients hepatitis B C ALT &gt; 300 IU/L Participants present one cause commonly associate secondary NAFLD ( drug , surgical procedure , environmental toxin , total parenteral nutrition ) Alcohol ingestion great 40 gr per week Abnormal Lipid profile ( TG &gt; 500 , LDL &gt; 160 ) Patients hypertension , diabetes mellitus , coronary heart disease Fibroscan score 7.9 kp pregnancy , lactation Drug addiction Reynolds Risk Score &gt; 10 % Not consent study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Non-alcoholic steatohepatitis , Atorvastatin , L-Carnitine</keyword>
</DOC>